Literature DB >> 17442911

The decrease in breast-cancer incidence in 2003 in the United States.

Peter M Ravdin1, Kathleen A Cronin, Nadia Howlader, Christine D Berg, Rowan T Chlebowski, Eric J Feuer, Brenda K Edwards, Donald A Berry.   

Abstract

An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries shows that the age-adjusted incidence rate of breast cancer in women in the United States fell sharply (by 6.7%) in 2003, as compared with the rate in 2002. Data from 2004 showed a leveling off relative to the 2003 rate, with little additional decrease. Regression analysis showed that the decrease began in mid-2002 and had begun to level off by mid-2003. A comparison of incidence rates in 2001 with those in 2004 (omitting the years in which the incidence was changing) showed that the decrease in annual age-adjusted incidence was 8.6% (95% confidence interval [CI], 6.8 to 10.4). The decrease was evident only in women who were 50 years of age or older and was more evident in cancers that were estrogen-receptor-positive than in those that were estrogen-receptor-negative. The decrease in breast-cancer incidence seems to be temporally related to the first report of the Women's Health Initiative and the ensuing drop in the use of hormone-replacement therapy among postmenopausal women in the United States. The contributions of other causes to the change in incidence seem less likely to have played a major role but have not been excluded. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442911     DOI: 10.1056/NEJMsr070105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  246 in total

1.  Disappearing breast cancers.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2012-04       Impact factor: 3.677

2.  Climacteric Complaints after Breast Cancer - Is HRT an Option?

Authors:  Christian F Singer
Journal:  Breast Care (Basel)       Date:  2008-06-20       Impact factor: 2.860

3.  Estrogen implants: embodiments of deeper problems in the marketing of drugs.

Authors:  Gordon Schiff; Judy Norsigian
Journal:  J Gen Intern Med       Date:  2010-09       Impact factor: 5.128

4.  Could recent decreases in breast cancer incidence really be due to lower HRT use? Trends in attributable risk for modifiable breast cancer risk factors in Canadian women.

Authors:  C Ineke Neutel; Howard Morrison
Journal:  Can J Public Health       Date:  2010 Sep-Oct

5.  VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.

Authors:  Lei Zhang; Guiying Wang; Lin Wang; Chenlin Song; Ye Leng; Xinhua Wang; Jiuhong Kang
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

6.  Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Authors:  Diana S M Buist; Rod Walker; Erin J Aiello Bowles; Patricia A Carney; Stephen H Taplin; Tracy Onega; Karla Kerlikowske; Walter Clinton; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-01       Impact factor: 4.254

7.  Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

Authors:  Jen-Liang Su; Poshen B Chen; Ya-Huey Chen; Shang-Chih Chen; Yi-Wen Chang; Yi-Hua Jan; Xiaoyun Cheng; Michael Hsiao; Mien-Chie Hung
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

8.  Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Maeve Mullooly; Zeina G Khodr; Cher M Dallal; Sarah J Nyante; Mark E Sherman; Roni Falk; Linda M Liao; Jeffrey Love; Louise A Brinton; Gretchen L Gierach
Journal:  Am J Epidemiol       Date:  2017-12-15       Impact factor: 4.897

9.  Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis.

Authors:  Eleni Linos; Demetri Spanos; Bernard A Rosner; Katerina Linos; Therese Hesketh; Jian Ding Qu; Yu-Tang Gao; Wei Zheng; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

10.  Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Douglas Richesson; Michael F Leitzmann; Gretchen L Gierach; Arthur Schatzkin; Traci Mouw; Albert R Hollenbeck; James V Lacey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.